955 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Dahi
    Dahi
  4. Ponce
    Ponce
  5. Shah
    Shah
  6. Sauter
    Sauter
  7. Jakubowski
    Jakubowski
  8. Papadopoulos
    Papadopoulos
  9. Devlin
    Devlin
  10. Scordo
    Scordo

Groups

  1. CTCR Scholars (955)
  2. MSK Grad Students (955)
  3. Master of Science in Clinical and Translational Cancer Research (955)
  4. Department of Medicine (853)
  5. Hematologic Malignancies, Division of (651)
  6. Center for Hematologic Malignancies (630)
  7. Survivorship Research (578)
  8. Bone Marrow Transplant (574)
  9. Epidemiology and Biostatistics (453)
  10. Biostatistics Service (414)
  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (519)
  2. Journal Article (329)
  3. Review (40)
  4. Miscellaneous (16)
  5. Research Letter (15)
  6. Editorial (14)
  7. Correspondence (12)
  8. Conference Paper (4)
  9. Book Section (3)
  10. Guidelines (3)
Groups
  1. CTCR Scholars (955)
  2. MSK Grad Students (955)
  3. Master of Science in Clinical and Translational Cancer Research (955)
  4. Department of Medicine (853)
  5. Hematologic Malignancies, Division of (651)
  6. Center for Hematologic Malignancies (630)

More Groups

People
  1. Sergio Giralt (378)
  2. Miguel-Angel Perales (356)
  3. Parastoo Dahi (294)
  4. Sean Devlin (265)
  5. Doris Ponce (254)
  6. Roni Tamari (208)

More People

Years
  1. 2025 (41)
  2. 2024 (109)
  3. 2023 (140)
  4. 2022 (121)
  5. 2021 (104)
  6. 2020 (119)

More Years

Publications
  1. Blood (191)
  2. Biology of Blood and Marrow Transplantation (153)
  3. Journal of Clinical Oncology (79)
  4. Annals of Surgical Oncology (78)
  5. Bone Marrow Transplantation (55)
  6. Transplantation and Cellular Therapy (42)

More Publications

Publishers
  1. American Society of Hematology (223)
  2. Elsevier Inc. (219)
  3. Springer (90)
  4. American Society of Clinical Oncology (87)
  5. Nature Publishing Group (82)
  6. American Association for Cancer Research (29)

More Publishers

Results (955)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multi-center biologic assignment trial comparing reduced intensity allogeneic hematopoietic cell transplantation to hypomethylating therapy or best supportive care in patients aged 50-75 with advanced myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102
    Meeting Abstract

    Nakamura, R.; Saber, W.; Martens, M. J.; Ramirez, A.; Scott, B. L.; Oran, B.; Leifer, E.; Tamari, R.; Mishra, A.; Maziarz, R. T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Successful treatment of mature T-cell lymphoma with allogeneic stem cell transplantation: The largest multicenter retrospective analysis
    Meeting Abstract

    Mehta-Shah, N.; Kommalapati, A.; Teja, S.; Cashen, A. F.; Dahi, P. B.; Sauter, C. S.; Moskowitz, A. J.; Jacobsen, E. D.; William, B. M.; Ozga, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Prognostic value of circulating tumor DNA (ctDNA) in autologous stem cell graft and post-transplant plasma samples among patients with diffuse large B-cell lymphoma
    Meeting Abstract

    Merryman, R. W.; Redd, R. A.; Taranto, E.; Ahmed, G.; Jeter, E.; McHugh, K. M.; Brown, J. R.; Crombie, J.; Davids, M. S.; Fisher, D. C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interim analysis from a prospective multicenter study of next-generation sequencing minimal residual disease assessment and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma
    Meeting Abstract

    Kumar, A.; Westin, J.; Schuster, S. J.; Nowakowski, G. S.; Lossos, I. S.; Batlevi, C. L.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • CD5-positive marginal zone lymphoma: Clinical characteristics of the MSKCC Cohort, and comparison with the CD5-negative population
    Meeting Abstract

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Lia Palomba, M.; Noy, A.; Matasar, M. J.; Caron, P.; Hamilton, A.; Hamlin, P. A.; Kumar, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • TCR repertoires in graft-versus-host-disease (GVHD)-target tissues reveals tissue specificity of the alloimmune response
    Meeting Abstract

    DeWolf, S.; Nichols, K.; Nguyen, C. L.; Giardina, P. A.; Slingerland, J. B.; Elias, H.; Kappangantula, R.; Baez, P.; Murali, R.; Hayashi, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save